Guidelines for the management of anticoagulant therapy.
D000208:Acute Disease; D000925:Anticoagulants / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy; D002471:Cell Transformation, Neoplastic / Q000187:drug effects; D004211:Disseminated Intravascular Coagulation / Q000188:drug therapy; D004305:Dose-Response Relationship, Drug; D004621:Embolization, Therapeutic; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced; D006493:Heparin / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D008943:Mitral Valve / Q000187:drug effects; D011183:Postoperative Complications / Q000517:prevention & control; D011247:Pregnancy; D011655:Pulmonary Embolism / Q000188:drug therapy; D013921:Thrombocytopenia / Q000139:chemically induced; D013923:Thromboembolism / Q000188:drug therapy; D013924:Thrombophlebitis / Q000188:drug therapy; D014812:Vitamin K / Q000627:therapeutic use; D014859:Warfarin / Q000009:adverse effects / Q000627:therapeutic use
D000925:Anticoagulants; D014812:Vitamin K; D014859:Warfarin; D006493:Heparin